https://a-biodesign.com/2026/03/24/advanced-biodesign-strengthens-early-access-program-outcomes-confirms-steady-progress-of-odyssey-clinical-trial-and-announces-upcoming-scientific-presentations/2026-03-24T08:23:08+00:00monthlyhttps://a-biodesign.com/a-propos/2026-03-15T18:21:45+00:00weekly0.6https://a-biodesign.com/2025/12/05/advanced-biodesign-to-present-groundbreaking-research-data-on-aml-at-the-67th-ash-annual-meeting/2025-12-05T15:01:56+00:00monthlyhttps://a-biodesign.com/privacy-policy/2025-11-13T10:29:17+00:00weekly0.6https://a-biodesign.com/legal/2025-11-13T10:28:41+00:00weekly0.6https://a-biodesign.com/2025/11/10/media-coverage-advanced-biodesign-featured-in-le-figaro-accelerating-innovation-against-resistant-cancers/2025-11-10T09:38:40+00:00monthlyhttps://a-biodesign.com/2025/11/07/advanced-biodesign-announces-publication-in-hemasphere-uncovering-novel-mechanism-driving-chemoresistance-in-acute-myeloid-leukemia/2025-11-07T11:00:44+00:00monthlyhttps://a-biodesign.com/2025/10/01/advanced-biodesign-publishes-groundbreaking-study-in-cell-chemical-biology-introducing-abd-0171-a-next-generation-aldh1-inhibitor-for-resistant-solid-tumors/2025-10-01T08:22:42+00:00monthlyhttps://a-biodesign.com/2025/09/03/advanced-biodesign-announces-first-patient-treated-under-compassionate-access-for-abd-3001-in-relapse-and-refractory-t-cell-cell-acute-lymphoblastic-leukemia/https://a-biodesign.com/wp-content/uploads/2025/09/create-a-highly-detailed-high-resolution-image-depicting-a-laboratory-1.pngcreate-a-highly-detailed-high-resolution-image-depicting-a-laboratoryhttps://a-biodesign.com/wp-content/uploads/2025/09/create-a-highly-detailed-high-resolution-image-depicting-a-laboratory.pngcreate-a-highly-detailed-high-resolution-image-depicting-a-laboratoryhttps://a-biodesign.com/wp-content/uploads/2025/09/image.pngimage2025-09-03T11:58:47+00:00monthlyhttps://a-biodesign.com/2025/05/27/advanced-biodesign-announces-positive-interim-results-from-phase-1-of-the-odyssey-clinical-trial/2025-05-27T08:33:12+00:00monthlyhttps://a-biodesign.com/2025/04/28/advanced-biodesign-to-present-preclinical-proof-of-concept-of-abd-0171-in-mss-colorectal-cancer-at-the-aacr-annual-meeting-2025/2025-04-28T06:45:07+00:00monthlyhttps://a-biodesign.com/investors/https://a-biodesign.com/wp-content/uploads/2024/09/th.jpgth2025-03-13T10:46:26+00:00weekly0.6https://a-biodesign.com/pipeline/https://a-biodesign.com/wp-content/uploads/2024/09/pipeline.jpgpipelinehttps://a-biodesign.com/wp-content/uploads/2024/09/pipeline.gifpipeline2025-03-13T10:37:49+00:00weekly0.6https://a-biodesign.com/2024/06/04/advanced-biodesign-announces-exceptional-first-in-human-results-for-its-innovative-treatment-against-acute-myeloid-leukemia/2025-03-11T14:50:31+00:00monthlyhttps://a-biodesign.com/2025/03/04/advanced-biodesign-announces-first-patient-dosed-in-odyssey/https://a-biodesign.com/wp-content/uploads/2025/03/pexels-photo-7723562.jpegruban espace de copie conceptuel flatlayPhoto de Tara Winstead sur <a href="https://www.pexels.com/fr-fr/photo/ruban-espace-de-copie-conceptuel-flatlay-7723562/" rel="nofollow">Pexels.com</a>2025-03-04T09:32:01+00:00monthlyhttps://a-biodesign.com/2024/11/04/advanced-biodesign-is-nominee-as-best-startup-for-2024-prix-galien-usa/2024-11-04T09:32:58+00:00monthlyhttps://a-biodesign.com/2024/10/30/advanced-biodesign-accelerates-odyssey-clinical-trial-with-a-new-design-following-abd-3001s-highly-promising-initial-results-in-acute-myeloid-leukemia/2024-10-30T15:11:55+00:00monthlyhttps://a-biodesign.com/2024/10/29/advanced-biodesign-a-new-study-published-in-the-journal-of-cellular-molecular-medicine-on-the-involvement-of-aldh-activity-in-r-r-aml/2024-10-29T13:25:54+00:00monthlyhttps://a-biodesign.com/2023/07/24/advanced-biodesign-winner-of-the-france-2030-plans-call-for-i-demo-projects-to-finance-its-odyssey-clinical-trial-with-up-to-e3m/2024-10-02T11:52:20+00:00monthlyhttps://a-biodesign.com/contact/2024-09-17T12:49:46+00:00weekly0.6https://a-biodesign.com/2024/03/27/advanced-biodesign-joins-forces-with-gtp-bioways-to-startmanufacturing-of-its-innovative-treatment-for-acute-myeloidleukemia-aml/2024-09-16T15:52:36+00:00monthlyhttps://a-biodesign.com/news/2024-09-16T15:46:18+00:00weekly0.6https://a-biodesign.comdaily1.02026-03-24T08:23:08+00:00